U.S. Pharmacist

• Gut Microbiota and Cardiovascular Drugs This article explores the the complex relationship between the gut microbiome and various common cardiovascular drugs. How might a patient's microbiome influence drug pharmacokinetics?
  U.S. Pharmacist, May 17, 2023
• Neurologic Lyme Disease and the Role of the Pharmacist Learn about the neurological manifestations of Lyme disease, and the role of the pharmacist in its treatment and prevention.
  U.S. Pharmacist, May 03, 2023
• Oral Antivirals for High-Risk COVID-19 Patients Review and compare the safety, efficacy, and clinical data for molnupiravir and ritonavir-boosted nirmatrelvir, two antivirals approved for the treatment of COVID-19 in high risk patients.
  U.S. Pharmacist, December 05, 2022
• Erectile Dysfunction: Considerations in Special Populations This paper presents an overview of risk factors and predictors of erectile dysfunction, with a focus on patients with diabetes and cardiovascular disease. What are the available treatment options?
  U.S. Pharmacist, November 28, 2022
• Insomnia Treatment: A Focus on Orexin Receptor Antagonists This comprehensive review details the various classes of medications currently available for treatment of insomnia, highlighting the most recently approved option, orexin receptor antagonists.
  U.S. Pharmacist, August 26, 2022
• A Review of Inguinal and Hiatal Hernia Management How can pharmacists support patients who have undergone surgical as well as non-surgical treatment for hernia? Review pharmacologic and nonpharmacologic approaches to care in this article.
  U.S. Pharmacist, August 01, 2022
• Summarizing the 2021 Updated GOLD Guidelines for COPD Updated guidelines from the Global Initiative for Chronic Obstructive Lung Disease includes information on the use of e-cigarettes, triple therapy, and the impact of SARS-CoV-2 on patients with COPD.
  U.S. Pharmacist, September 01, 2021
• An Overview of Male Osteoporosis While osteoporosis is often thought of as a disease of postmenopausal women, it can affect men as well. Review the risk factors, causes, and management of male osteoporosis in this article.
  U.S. Pharmacist, August 25, 2021
• Managing Social Anxiety Disorder Review the psychopharmacological therapeutic options available for social anxiety disorder, including SSRIs, SNRIs, and other classes of psychoactive agents.
  U.S. Pharmacist, August 18, 2021
• The Role of the Pharmacist in Overcoming Vaccine Hesitancy Pharmacists can play a pivotal role in combating vaccine hesitancy, dispelling common myths and concerns about vaccine-related adverse effects, and improving vaccination rates.
  U.S. Pharmacist, August 11, 2021
• Challenges in Managing, Preventing Rheumatoid Arthritis Pain Review treatment strategies and the variety of disease-modifying and targeted biologics available for the treatment of rheumatoid arthritis. What adjunctive agents and analgesics are also useful?
  U.S. Pharmacist, August 04, 2021
• Newly Approved HIV Medications Review the novel antiretroviral drugs and drug combinations which have been recently approved for the treatment of HIV.
  U.S. Pharmacist, December 29, 2020
• The Effect of COVID-19 on Patients With Diabetes This article explores potential mechanisms associated with increased risk of negative COVID-19 outcomes in patients with diabetes, and the impact of comorbidities in these patients.
  U.S. Pharmacist, December 22, 2020
• Human Papillomavirus (HPV) Vaccine Update Review the latest ACIP recommendations regarding the HPV vaccine, as well as its safety profile, in this primer.
  U.S. Pharmacist, December 15, 2020
• Pharmacotherapy in Hospitalized Patients With COVID-19 Pneumonia While pharmacotherapy in COVID-19 is constantly evolving, this article summarizes general recommendations based on current best evidence for support of hospitalized patients with COVID-19 pneumonia.
  U.S. Pharmacist, September 25, 2020
• Discussing Brand Versus Generic Medications Many patients remain resistant to using generic medications. This article outlines discussion points and resources to educate patients and help overcome barriers to their use of generic drugs.
  U.S. Pharmacist, August 11, 2020
• Managing Treatment-Resistant Depression Nearly 25% of patients may have an inadequate response to depression therapy. Review the diagnosis and available therapeutic options for treatment-resistant depression in this article.
  U.S. Pharmacist, July 28, 2020
• Understanding Antimicrobial Resistance Which bacteria are considered the most threatening resistant organisms in the U.S.? Learn about their mechanisms of resistance and new antibiotics to combat them in this review.
  U.S. Pharmacist, June 12, 2020
• Pharmacist's Guide to CBD Oil Cannabidiol, or CBD, is becoming more readily available and gaining popularity in the U.S. What should you know in order to counsel patients effectively regarding legalities, indications, and usage?
  U.S. Pharmacist, June 05, 2020
• Dental Pain Advice about dental pain is often sought from pharmacists, but how can you distinguish between benign and serious etiologies?
  U.S. Pharmacist, July 25, 2020